flavopiridol/imatinib mesylate

Known as: FLAVO/STI571 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2005
0119992005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Ph. L. S e l a t e r , D e s c r i p t i o n of a New T a n a g e r of the Genus Euphonia. (Proceed. Zool. Soc. April 28, 1857… (More)
Is this relevant?
2002
2002
The adenosine triphosphate binding-site-directed agent STI571 and the tyrphostin adaphostin are undergoing evaluation as bcr/abl… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Combination of STI571, a tyrosine kinase inhibitor, with other drugs may be beneficial in the treatment of chronic myeloid… (More)
Is this relevant?
Review
2002
Review
2002
Chronic myeloid leukemia (CML), in most of the cases, is the molecular consequence of the t(9,22) translocation, resulting in the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The ABL-specific tyrosine kinase inhibitor STI571 (formerly CGP57148B) induced cytogenetic remissions in 33% of chronic… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
1999
1999
The synthetic flavone flavopiridol can be cytostatic or cytotoxic to mammalian cells, depending on the concentration of the drug… (More)
Is this relevant?